← All stocks

Candel Therapeutics, Inc.

CADL Net buying
CIK 0001841387 #2585 in the set updated 17 Sep 2026
Bought (12 mo)
$3.00M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$3.55M
$1.01M on a plan · $2.54M straight out of an exercise
Sold at will
$0.00
0 of 5 sales
Net
−$550.71K
+$3.00M against sales at will

By person

11 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Tak Paul Peter
Chief Executive Officer
$3.16M (2) scheduled
−$3.16M
113,321
$1.18M
−65.7%
Manning Paul B
Director
$3.00M (1)
+$3.00M
2,763,527
$28.90M
Barone Francesca
Chief Scientific Officer
$235.77K (1) scheduled
−$235.77K
77,362
$808.93K
−51.6%
Tyagarajan Seshu
Chief Technology Officer
$154.15K (2) scheduled
−$154.15K
76,865
$803.73K
−53.7%
Aguilar-Cordova Estuardo
10% owner
283,790
$2.97M
−85.0%
Martell Christopher
Director
111,349
$1.16M
PAPA JOSEPH C
Director
64,239
$671.71K
Nichols William Garrett
Chief Medical Officer
52,493
$548.89K
−54.1%
Schoch Charles
Chief Financial Officer
43,391
$453.71K
−30.6%
Nabel Gary J.
Director
5,353
$55.97K
Loggia Nicoletta
Director
2,141
$22.39K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 32,475,537 to 76,518,565 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Tak Paul Peter
11 Sep 2026
Chief Executive Officer
Sold on a plan
59,379
$10.46
$620.89K
Tyagarajan Seshu
17 Aug 2026
Chief Technology Officer
Sold on a plan
7,000
$12.00
$84.00K
Tyagarajan Seshu
29 Jun 2026
Chief Technology Officer
Sold on a plan
7,000
$10.02
$70.15K
Barone Francesca
29 Jun 2026
Chief Scientific Officer
Sold on a plan
23,447
$10.06
$235.77K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 125,000
History held since 29 Jul 2021